Christopher R King

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 70:1472-7. 2008
  2. ncbi Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomy
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 73:1017-22. 2009
  3. ncbi Improved outcomes with higher doses for salvage radiotherapy after prostatectomy
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 71:23-7. 2008
  4. ncbi Prognostic significance of prostate cancer originating from the transition zone
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Urol Oncol 27:592-7. 2009
  5. ncbi Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database
    Christopher R King
    Division of Urologic Oncology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:921-6. 2007
  6. ncbi Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 73:1043-8. 2009
  7. ncbi Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:732-7. 2007
  8. ncbi Incidental testicular irradiation from prostate IMRT: it all adds up
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 77:484-9. 2010
  9. ncbi Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy
    Deep A Patel
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305-5847, USA
    J Clin Oncol 23:6157-62. 2005
  10. ncbi A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes
    Annie Hsu
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 68:898-902. 2007

Detail Information

Publications26

  1. ncbi Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 70:1472-7. 2008
    ..Identification of patients most likely to benefit from salvage radiotherapy (RT) using postoperative (postop) prostate-specific antigen (PSA) kinetics...
  2. ncbi Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomy
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 73:1017-22. 2009
    ..Using body mass index (BMI) as a measure of obesity, we tested its role as a risk factor for patients receiving salvage RT after prostatectomy...
  3. ncbi Improved outcomes with higher doses for salvage radiotherapy after prostatectomy
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 71:23-7. 2008
    ..To evaluate relapse-free survival with higher doses for patients receiving salvage radiotherapy (RT) after radical prostatectomy (RP)...
  4. ncbi Prognostic significance of prostate cancer originating from the transition zone
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Urol Oncol 27:592-7. 2009
    ..To understand the influence of tumor location, we compared bRFS for TZ and PZ cancers stratified for risk using known clinical and pathological prognostic factors...
  5. ncbi Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database
    Christopher R King
    Division of Urologic Oncology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:921-6. 2007
    ....
  6. ncbi Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 73:1043-8. 2009
    ..The radiobiology of prostate cancer favors a hypofractionated dose regimen. We report results of a prospective Phase II clinical trial of stereotactic body radiotherapy (SBRT) for localized prostate cancer...
  7. ncbi Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:732-7. 2007
    ..We studied the timing, cutoff levels, and method of calculation to better define its usefulness...
  8. ncbi Incidental testicular irradiation from prostate IMRT: it all adds up
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford Cancer Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 77:484-9. 2010
    ..To identify the technical aspects of image-guided intensity-modulated radiation therapy (IMRT) for localized prostate cancer that could result in a clinically meaningful incidental dose to the testes...
  9. ncbi Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy
    Deep A Patel
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305-5847, USA
    J Clin Oncol 23:6157-62. 2005
    ..Its inclusion will be useful in risk stratification, evaluation for alternatives to surgery, and patient selection for neoadjuvant or adjuvant therapies as part of randomized clinical trials...
  10. ncbi A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes
    Annie Hsu
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 68:898-902. 2007
    ..To study the impact on nodal coverage and dose to fixed organs at risk when using daily fiducial localization of the prostate to deliver intensity-modulated radiotherapy (IMRT)...
  11. ncbi Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients
    Michael T Spiotto
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 69:54-61. 2007
    ..To compare the biochemical relapse-free survival (bRFS) among patients receiving whole pelvic radiotherapy (WPRT) vs. prostate bed RT (PBRT) after radical prostatectomy...
  12. ncbi Investigation of linac-based image-guided hypofractionated prostate radiotherapy
    Todd Pawlicki
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Med Dosim 32:71-9. 2007
    ..During this study, we have also uncovered opportunities for improvement of the on-board imaging hardware/software implementation that would further enhance performance in this regard...
  13. ncbi Radiotherapy after prostatectomy: is the evidence for dose escalation out there?
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 71:346-50. 2008
    ..To study the effective doses of radiotherapy (RT) after prostatectomy in search for evidence of a dose-response...
  14. ncbi Does hormone therapy exacerbate the adverse effects of radiotherapy in men with prostate cancer? A quality of life study
    Jonathan D Grant
    Department of Radiation Oncology, University of California Los Angeles School of Medicine, Los Angeles, California 90095, USA
    J Urol 185:1674-80. 2011
    ....
  15. ncbi Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients
    Christopher R King
    Division of Urologic Oncology, Department of Radiation, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 59:386-91. 2004
    ..This study examines the concordance patterns between biopsy and matched radical prostatectomy Gleason grade among patients undergoing an extended 10-core biopsy scheme to assess its reliability compared to sextant biopsies...
  16. ncbi Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults
    Phuoc T Tran
    Department of Radiation Oncology, Stanford Cancer Center, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 72:1146-53. 2008
    ..To analyze the outcomes of and identify prognostic factors for patients treated with surgery and intraoperative radiotherapy (IORT) for locally advanced and recurrent soft-tissue sarcoma in adults from a single institution...
  17. ncbi Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 67:1229-34. 2006
    ..Prostate biopsy findings are known to undergrade prostate cancer compared with the pathologic specimens yet remain the only grade guiding disease management...
  18. ncbi Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 59:341-7. 2004
    ....
  19. ncbi Prostate biopsy volume indices do not predict for significant Gleason upgrading
    Christopher R King
    Division of Urologic Oncology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305, USA
    Am J Clin Oncol 28:125-9. 2005
    ..This suggests that the correlation that exists between such volume surrogates and outcomes after surgery reflect tumor volume effects only, independently of any possible association between tumor volume and Gleason grade...
  20. ncbi Intrafractional motion of the prostate during hypofractionated radiotherapy
    Yaoqin Xie
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 72:236-46. 2008
    ..To report the characteristics of prostate motion as tracked by the stereoscopic X-ray images of the implanted fiducials during hypofractionated radiotherapy with CyberKnife...
  21. ncbi A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD)
    Gary Luxton
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Drive, Stanford, CA 94305, USA
    Phys Med Biol 53:23-36. 2008
    ..The inverse equation expresses EUD as a function of NTCP and is used to generate a table of EUD versus normal tissue complication probability for the Emami-Burman parameter fits as well as for OAR parameter sets from more recent data...
  22. ncbi The timing of salvage radiotherapy after radical prostatectomy: a systematic review
    Christopher R King
    Department of Radiation Oncology, UCLA School of Medicine, Los Angeles, California 90095, USA
    Int J Radiat Oncol Biol Phys 84:104-11. 2012
    ..Defining the optimal patient and treatment factors is essential and is particularly relevant within the context of adjuvant vs early vs delayed postoperative radiotherapy (RT)...
  23. ncbi Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial
    Ellen A Wiegner
    Department of Radiation Oncology, Stanford University School of Medicine, CA, USA
    Int J Radiat Oncol Biol Phys 78:442-8. 2010
    ..To study the sexual quality of life for prostate cancer patients after stereotactic body radiotherapy (SBRT)...
  24. ncbi LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Brachytherapy 1:219-26. 2002
    ....
  25. ncbi CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA
    Technol Cancer Res Treat 2:25-30. 2003
    ..These capabilities are essential if one contemplates hypo-fractionated regimens with large dose-per-fraction sizes (>5Gy to 10Gy) and dose-escalation...
  26. ncbi Yes, the alpha/beta ratio for prostate cancer is low or "methinks the lady doth protest too much...about a low alpha/beta that is"
    Christopher R King
    Int J Radiat Oncol Biol Phys 54:626-7; author reply 627-8. 2002